Cash Flow Mankind Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Profit Before Tax
2,399.00
1,671.00
1,974.00
1,691.00
1,437.00
Adjustment
212.00
298.00
30.00
-5.00
108.00
Changes In working Capital
20.00
166.00
-586.00
-94.00
-145.00
Cash Flow after changes in Working Capital
2,631.00
2,136.00
1,419.00
1,591.00
1,400.00
Cash Flow from Operating Activities
2,152.00
1,813.00
919.00
1,137.00
1,069.00
Cash Flow from Investing Activities
-2,080.00
-1,051.00
-1,368.00
-1,221.00
-435.00
Cash Flow from Financing Activities
5.00
-739.00
604.00
-7.00
-530.00
Net Cash Inflow / Outflow
77.00
21.00
155.00
-92.00
103.00
Opening Cash & Cash Equivalents
304.00
283.00
127.00
219.00
116.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
382.00
304.00
283.00
127.00
219.00
Compare Cash Flow Results of Mankind Pharma
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
2399.36
2352.11
47.00
2.01%
Adjustment
212.2
993.99
-781.00
-78.65%
Changes In working Capital
20.42
418.08
-398.00
-95.12%
Cash Flow after changes in Working Capital
2631.98
3764.18
-1,133.00
-30.08%
Cash Flow from Operating Activities
2152.45
3266.08
-1,114.00
-34.10%
Cash Flow from Investing Activities
-2080.52
-159.83
-1,921.00
-1201.71%
Cash Flow from Financing Activities
5.27
-2779.64
2,784.00
100.19%
Net Cash Inflow / Outflow
77.19
326.61
-249.00
-76.37%
Opening Cash & Cash Equivalents
304.82
508.53
-204.00
-40.06%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
382.01
835.14
-453.00
-54.26%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 18.70% vs 97.14% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
2,152.45
1,813.30
18.70%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
